메뉴 건너뛰기




Volumn 82, Issue 1, 2008, Pages 435-450

Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN; HLA B7 ANTIGEN; HLA DR ANTIGEN; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS VACCINE INX102 3697; VIRUS VECTOR; VIRUS VECTOR INX102 0557;

EID: 37349054681     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01505-07     Document Type: Article
Times cited : (95)

References (57)
  • 2
    • 0037313995 scopus 로고    scopus 로고
    • Derivation of HLA-B*0702 transgenic mice: Functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes
    • Alexander, J., C. Oseroff, J. Sidney, and A. Sette. 2003. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes. Hum. Immunol. 64:211-223.
    • (2003) Hum. Immunol , vol.64 , pp. 211-223
    • Alexander, J.1    Oseroff, C.2    Sidney, J.3    Sette, A.4
  • 4
    • 0345306198 scopus 로고    scopus 로고
    • Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control
    • Bertoletti, A., M. Maini, and R. Williams. 2003. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res. 60:61-66.
    • (2003) Antiviral Res , vol.60 , pp. 61-66
    • Bertoletti, A.1    Maini, M.2    Williams, R.3
  • 5
    • 0030811688 scopus 로고    scopus 로고
    • Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis
    • Bertoni, R., J. Sidney, P. Fowler, R. W. Chesnut, F. V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Investig. 100:503-513.
    • (1997) J. Clin. Investig , vol.100 , pp. 503-513
    • Bertoni, R.1    Sidney, J.2    Fowler, P.3    Chesnut, R.W.4    Chisari, F.V.5    Sette, A.6
  • 6
    • 0141532308 scopus 로고    scopus 로고
    • Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease
    • Bienzle, U., M. Gunther, R. Neuhaus, P. Vandepapeliere, J. Vollmar, A. Lun, and P. Neuhaus. 2003. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 38:811-819.
    • (2003) Hepatology , vol.38 , pp. 811-819
    • Bienzle, U.1    Gunther, M.2    Neuhaus, R.3    Vandepapeliere, P.4    Vollmar, J.5    Lun, A.6    Neuhaus, P.7
  • 10
    • 33746166392 scopus 로고    scopus 로고
    • Predicting population coverage of T-cell epitope-based diagnostics and vaccines
    • Bui, H. H., J. Sidney, K. Dinh, S. Southwood, M. J. Newman, and A. Sette. 2006. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7:153-157.
    • (2006) BMC Bioinformatics , vol.7 , pp. 153-157
    • Bui, H.H.1    Sidney, J.2    Dinh, K.3    Southwood, S.4    Newman, M.J.5    Sette, A.6
  • 11
    • 33745660321 scopus 로고    scopus 로고
    • Antiviral treatment for chronic hepatitis B virus infection-immune modulation or viral suppression?
    • Buster, E. H., and H. L. Janssen. 2006. Antiviral treatment for chronic hepatitis B virus infection-immune modulation or viral suppression? Neth. J. Med. 64:175-185.
    • (2006) Neth. J. Med , vol.64 , pp. 175-185
    • Buster, E.H.1    Janssen, H.L.2
  • 13
    • 0029087093 scopus 로고    scopus 로고
    • Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17:261-281.
    • Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17:261-281.
  • 16
    • 0033617583 scopus 로고    scopus 로고
    • Viral clearance without destruction of infected cells during acute HBV infection
    • Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
    • (1999) Science , vol.284 , pp. 825-829
    • Guidotti, L.G.1    Rochford, R.2    Chung, J.3    Shapiro, M.4    Purcell, R.5    Chisari, F.V.6
  • 17
    • 0035961542 scopus 로고    scopus 로고
    • Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications
    • Hilleman, M. R. 2001. Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications. Vaccine 19:1837-1848.
    • (2001) Vaccine , vol.19 , pp. 1837-1848
    • Hilleman, M.R.1
  • 20
    • 0037019913 scopus 로고    scopus 로고
    • Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: Induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
    • Jung, M. C., N. Gruner, R. Zachoval, W. Schraut, T. Gerlach, H. Diepolder, C. A. Schirren, M. Page, J. Bailey, E. Birtles, E. Whitehead, J. Trojan, S. Zeuzem, and G. R. Pape. 2002. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 20:3598-3612.
    • (2002) Vaccine , vol.20 , pp. 3598-3612
    • Jung, M.C.1    Gruner, N.2    Zachoval, R.3    Schraut, W.4    Gerlach, T.5    Diepolder, H.6    Schirren, C.A.7    Page, M.8    Bailey, J.9    Birtles, E.10    Whitehead, E.11    Trojan, J.12    Zeuzem, S.13    Pape, G.R.14
  • 21
    • 0036337681 scopus 로고    scopus 로고
    • Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: Implications for immunotherapy of persistent viral infections
    • Kakimi, K., M. Isogawa, J. Chung, A. Sette, and F. V. Chisari. 2002. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 76:8609-8620.
    • (2002) J. Virol , vol.76 , pp. 8609-8620
    • Kakimi, K.1    Isogawa, M.2    Chung, J.3    Sette, A.4    Chisari, F.V.5
  • 23
    • 1642410856 scopus 로고    scopus 로고
    • Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    • Lavanchy, D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11:97-107.
    • (2004) J. Viral Hepat , vol.11 , pp. 97-107
    • Lavanchy, D.1
  • 24
    • 0031204408 scopus 로고    scopus 로고
    • The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
    • Livingston, B. D., C. Crimi, H. Grey, G. Ishioka, F. V. Chisari, J. Fikes, H. Grey, R. W. Chesnut, and A. Sette. 1997. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol. 159:1383-1392.
    • (1997) J. Immunol , vol.159 , pp. 1383-1392
    • Livingston, B.D.1    Crimi, C.2    Grey, H.3    Ishioka, G.4    Chisari, F.V.5    Fikes, J.6    Grey, H.7    Chesnut, R.W.8    Sette, A.9
  • 26
    • 0035860626 scopus 로고    scopus 로고
    • Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
    • Livingston, B. D., M. Newman, C. Crimi, D. McKinney, R. Chesnut, and A. Sette. 2001. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19:4652-4660.
    • (2001) Vaccine , vol.19 , pp. 4652-4660
    • Livingston, B.D.1    Newman, M.2    Crimi, C.3    McKinney, D.4    Chesnut, R.5    Sette, A.6
  • 27
    • 0036604410 scopus 로고    scopus 로고
    • A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes
    • Livingston, B., C. Crimi, M. Newman, Y. Higashimoto, E. Appella, J. Sidney, and A. Sette. 2002. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J. Immunol. 168:5499-5506.
    • (2002) J. Immunol , vol.168 , pp. 5499-5506
    • Livingston, B.1    Crimi, C.2    Newman, M.3    Higashimoto, Y.4    Appella, E.5    Sidney, J.6    Sette, A.7
  • 28
    • 33847701354 scopus 로고    scopus 로고
    • Chronic hepatitis B
    • Lok, A. S., and B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45:507-539.
    • (2007) Hepatology , vol.45 , pp. 507-539
    • Lok, A.S.1    McMahon, B.J.2
  • 30
    • 20744456789 scopus 로고
    • Solid phase peptide synthesis I: The synthesis of a tetrapeptide
    • Merrifield, R. B. 1963. Solid phase peptide synthesis I: the synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149-2154.
    • (1963) J. Am. Chem. Soc , vol.85 , pp. 2149-2154
    • Merrifield, R.B.1
  • 31
    • 0037853316 scopus 로고    scopus 로고
    • New allele frequency database: http://www.allelefrequencies.net
    • Middleton, D., L. Menchaca, H. Rood, and R. Komerofsky. 2003. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61:403-407.
    • (2003) Tissue Antigens , vol.61 , pp. 403-407
    • Middleton, D.1    Menchaca, L.2    Rood, H.3    Komerofsky, R.4
  • 32
    • 0027394383 scopus 로고
    • HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis
    • Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H. J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751-762.
    • (1993) J. Exp. Med , vol.177 , pp. 751-762
    • Missale, G.1    Redeker, A.2    Person, J.3    Fowler, P.4    Guilhot, S.5    Schlicht, H.J.6    Ferrari, C.7    Chisari, F.V.8
  • 34
    • 0342614926 scopus 로고    scopus 로고
    • Codon usage tabulated from international DNA sequence databases: Status for the year 2000
    • Nakamura, Y., T. Gojobori, and T. Ikemura. 2000. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 28:292.
    • (2000) Nucleic Acids Res , vol.28 , pp. 292
    • Nakamura, Y.1    Gojobori, T.2    Ikemura, T.3
  • 37
    • 0018500742 scopus 로고
    • Use of a monoclonal antibody (W6/32) in structural studies in HLA-A,B,C, antigens
    • Parham, P., C. J. Barnstable, and W. F. Bodmer. 1979. Use of a monoclonal antibody (W6/32) in structural studies in HLA-A,B,C, antigens. J. Immunol. 123:342-349.
    • (1979) J. Immunol , vol.123 , pp. 342-349
    • Parham, P.1    Barnstable, C.J.2    Bodmer, W.F.3
  • 38
  • 39
    • 0028925535 scopus 로고
    • The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
    • Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
    • (1995) J. Exp. Med , vol.181 , pp. 1047-1058
    • Rehermann, B.1    Fowler, P.2    Sidney, J.3    Person, J.4    Redeker, A.5    Brown, M.6    Moss, B.7    Sette, A.8    Chisari, F.V.9
  • 40
    • 0030008076 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
    • Rehermann, B., D. Lau, J. H. Hoofnagle, and F. V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Investig. 97:1655-1665.
    • (1996) J. Clin. Investig , vol.97 , pp. 1655-1665
    • Rehermann, B.1    Lau, D.2    Hoofnagle, J.H.3    Chisari, F.V.4
  • 42
    • 0030959049 scopus 로고    scopus 로고
    • Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
    • Rossol, S., G. Marinos, P. Carucci, M. V. Singer, R. Williams, and N. V. Naoumov. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Investig. 99:3025-3033.
    • (1997) J. Clin. Investig , vol.99 , pp. 3025-3033
    • Rossol, S.1    Marinos, G.2    Carucci, P.3    Singer, M.V.4    Williams, R.5    Naoumov, N.V.6
  • 43
    • 0032992117 scopus 로고    scopus 로고
    • The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response
    • Schlaak, J. F., G. Tully, H. F. Lohr, G. Gerken, and K. H. Meyer zum Buschenfelde. 1999. The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. J. Hepatol. 30:353-358.
    • (1999) J. Hepatol , vol.30 , pp. 353-358
    • Schlaak, J.F.1    Tully, G.2    Lohr, H.F.3    Gerken, G.4    Meyer zum Buschenfelde, K.H.5
  • 47
    • 0033388724 scopus 로고    scopus 로고
    • Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
    • Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212.
    • (1999) Immunogenetics , vol.50 , pp. 201-212
    • Sette, A.1    Sidney, J.2
  • 49
    • 0024542612 scopus 로고
    • Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line
    • Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142:3320-3328.
    • (1989) J. Immunol , vol.142 , pp. 3320-3328
    • Shimizu, Y.1    DeMars, R.2
  • 51
    • 37349087430 scopus 로고    scopus 로고
    • Sidney, J., S. Southwood, C. Oseroff, M-F. del Guercio, A. Sette, and H. M. Grey. 1998. Measurement of MHC/peptide interactions by gel filtration, p. 18.3.1-18.3.19. In J. E. Coligan et al. (ed.), Current protocols in immunology John Wiley & Sons, New York, NY.
    • Sidney, J., S. Southwood, C. Oseroff, M-F. del Guercio, A. Sette, and H. M. Grey. 1998. Measurement of MHC/peptide interactions by gel filtration, p. 18.3.1-18.3.19. In J. E. Coligan et al. (ed.), Current protocols in immunology John Wiley & Sons, New York, NY.
  • 54
    • 0002752973 scopus 로고
    • Improved media for growing plasmic and cosmid clones
    • Tartof, K. D., and C. A. Hobbs. 1987. Improved media for growing plasmic and cosmid clones. Bethesda Res. Lab. Focus 9:12.
    • (1987) Bethesda Res. Lab. Focus , vol.9 , pp. 12
    • Tartof, K.D.1    Hobbs, C.A.2
  • 55
    • 0025729554 scopus 로고
    • Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
    • Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007-1015.
    • (1991) J. Exp. Med , vol.173 , pp. 1007-1015
    • Vitiello, A.1    Marchesini, D.2    Furze, J.3    Sherman, L.A.4    Chesnut, R.W.5
  • 57
    • 0024720605 scopus 로고
    • The RAMPS system: Simplified peptide synthesis for life science researchers
    • Wolfe, H. R., and R. R. Wilk. 1989. The RAMPS system: simplified peptide synthesis for life science researchers. Pept. Res. 2:352-356.
    • (1989) Pept. Res , vol.2 , pp. 352-356
    • Wolfe, H.R.1    Wilk, R.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.